The diagnosis of respiratory viruses by rapid point of care nucleic acid tests can dramatically enhance patient care during seasonal influenza epidemics. It can facilitate differentiation of Influenza A, B, RSV and SARS-CoV-2 , viruses. With PCR testing for Influenza, being the highly sensitive and specific test, healthcare professionals can precisely discern the etiology of the patient’s illness.